3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Neoplasms
2
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hearing Loss
1
Head and Neck Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Cardiotoxicity
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Cisplatin
32
Gemcitabine
21
Radiotherapy, Intensity-Modulated
16
toripalimab
14
Capecitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiotherapy
7
Drug Therapy
7
pembrolizumab
6
Platinum
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
1,2-diaminocyclohexaneplatinum II citrate
6
Docetaxel
5
tislelizumab
4
spartalizumab
4
camrelizumab
4
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
nimotuzumab
2
fludarabine
2
atezolizumab
2
Taxes
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Atorvastatin
×
1 year
×
Clear all
No trials found.